Clinical Trial Update: Safety Study of Flavocoxid in Duchenne Muscular Dystrophy [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating Flavocoxid in Duchenne Muscular Dystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Flavocoxid (flavocoxid)

Snippet

Sponsor: University of Messina | Conditions: Duchenne Muscular Dystrophy | Phase 1 | Status: COMPLETED